Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Inclusion Criteria:

• Patients with initial diagnosis of CSCR and no treatment so far

Exclusion Criteria:

• Therapy (drugs/laser) due to CSCR